Clearside Biomedical Inc (NAS:CLSD)
$ 1.15 0 (0%) Market Cap: 85.96 Mil Enterprise Value: 57.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Clearside Biomedical Inc at Stifel Healthcare Conference Transcript

Nov 16, 2022 / 01:35PM GMT
Release Date Price: $1.35 (-4.26%)
Annabel Samimy
Stifel Financial Corp. - Analyst

So good morning, everyone, and welcome to the Clearside Biomedical presentation. I'm Annabel Samimy, a biopharma analyst at Stifel. And it's our pleasure to have CEO, George Lasezkay here today with us as well as Tom Ciulla, Chief Medical Officer. So why don't we just start by kicking it off with a five-minute overview to get everyone on the same page.

George Lasezkay
Clearside Biomedical, Inc. - President & CEO

Sure. Thanks, Annabel. And it's great to be here. Appreciate the time. Appreciate the invite, and we're happy to be here. You've been with us a long time.

Annabel Samimy
Stifel Financial Corp. - Analyst

A little bit, yeah.

George Lasezkay
Clearside Biomedical, Inc. - President & CEO

And you've been with us a long time. But if you go back, what we've been trying to do at the company for a number of years is come up with a way that's safe, repeatable, and in-office procedure to administer drugs into the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot